FIELD: chemistry.
SUBSTANCE: invention relates to use of 11H-indeno[1,2-b]quinoxaline-11-one-oxime (IQ-1) as a hypolipidemic agent.
EFFECT: invention enables reducing blood serum cholesterol and triglycerides and widening the arsenal of hypolipidemic agents.
1 cl, 1 dwg, 5 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT BASED ON L-RHAMNOPYRANOSYL-6-O-METHYL-D-GALACTURONANE, HAVING HYPOLIPIDEMIC ACTIVITY | 2019 |
|
RU2699802C1 |
LIPID-CORRECTING AGENT OF SEAWEED | 2021 |
|
RU2767908C1 |
HYPOLIPIDEMIC PHYTOAGENT | 2013 |
|
RU2553309C2 |
USE OF RHODANINE DERIVATIVE 3-(2-PHENYLETHYL)-2-THIOXO-1,3 THIAZOLIDIN-4-ONE FOR CORRECTION OF METABOLIC DISORDERS | 2019 |
|
RU2768171C2 |
METHOD FOR SIMULATING DIET-INDUCED METABOLIC SYNDROME | 2020 |
|
RU2740007C1 |
METHOD FOR STEP-BY-STEP MODELING OF NONALCOHOLIC FATTY PANCREATIC DISEASE IN RATS | 2021 |
|
RU2770555C1 |
METHOD FOR MODELING ELECTROLYTIC NEPHROPATHY IN RATS | 2003 |
|
RU2256953C2 |
METHOD OF SIMULATING MULTIPLE ORGAN PATHOLOGY IN RATS | 2011 |
|
RU2453002C1 |
USE OF 2-METHYL-N-(2-METHYLPHENYL)-4-(2-FURYL)-5-CYANO-6-({2-[(4-ETHOXYPHENYL)AMINO]-2-OXOETHYL}THIO)-1,4 -DIHYDROPYRIDINE-3-CARBOXAMIDE AS HYPOGLYCEMIC, HYPOLIPIDEMIC AGENT THAT PROMOTES WEIGHT LOSS | 2023 |
|
RU2812569C1 |
HEMOSTIMULATING AGENT | 2017 |
|
RU2647833C1 |
Authors
Dates
2020-09-18—Published
2020-02-04—Filed